• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种在静止、增殖或分化状态下限制乳腺癌干细胞的新方法:利用凝胶应力与干细胞生长因子相结合。

A novel method to limit breast cancer stem cells in states of quiescence, proliferation or differentiation: Use of gel stress in combination with stem cell growth factors.

作者信息

Wang Jing, Liu Xiangming, Jiang Zhongmin, Li Lili, Cui Zhigang, Gao Yuan, Kong Di, Liu Xiaozhi

机构信息

Department of Tumor Surgery, Tianjin Nankai Hospital, Tianjin 300100, P.R. China.

Department of Esophageal Neoplasms, Cancer Hospital of Tianjin Medical University, Tianjin 300060, P.R. China.

出版信息

Oncol Lett. 2016 Aug;12(2):1355-1360. doi: 10.3892/ol.2016.4757. Epub 2016 Jun 22.

DOI:10.3892/ol.2016.4757
PMID:27446437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4950051/
Abstract

The majority of cancer stem cells exist in the G0, or quiescent phase of the cell cycle. However, the cells can escape quiescence following routine radiotherapy and chemotherapy, resulting in tumor recurrence. Presently, achieving the accurate regulation of cancer stem cell growth in order to study a specific state, including the quiescent (mostly G0 or G1 phase), proliferative (mostly S phase) or differential (mostly G2/M phase) states, can be challenging. This makes the determination of cell cycle state-specific characteristics and analysis of potential intervention treatments difficult, particularly for quiescent cells. Breast cancer stem cells were cultured on a soft or hard agar matrix surface in the presence or absence of stem cell growth factors. Cells could be successfully limited in either the quiescent, proliferative or differentiated states. These findings provide a foundation for further study of the cell cycle in breast cancer stem cells.

摘要

大多数癌症干细胞处于细胞周期的G0期或静止期。然而,这些细胞在常规放疗和化疗后可逃离静止状态,导致肿瘤复发。目前,要实现对癌症干细胞生长的精确调控以研究特定状态,包括静止(主要是G0或G1期)、增殖(主要是S期)或分化(主要是G2/M期)状态,可能具有挑战性。这使得确定细胞周期状态特异性特征以及分析潜在干预治疗变得困难,尤其是对于静止细胞。乳腺癌干细胞在有无干细胞生长因子的情况下,培养于软或硬琼脂基质表面。细胞能够成功地被限制在静止、增殖或分化状态。这些发现为进一步研究乳腺癌干细胞的细胞周期奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb37/4950051/ade7a3fd9500/ol-12-02-1355-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb37/4950051/b756619e5870/ol-12-02-1355-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb37/4950051/e8f2f4f48855/ol-12-02-1355-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb37/4950051/ade7a3fd9500/ol-12-02-1355-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb37/4950051/b756619e5870/ol-12-02-1355-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb37/4950051/e8f2f4f48855/ol-12-02-1355-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb37/4950051/ade7a3fd9500/ol-12-02-1355-g02.jpg

相似文献

1
A novel method to limit breast cancer stem cells in states of quiescence, proliferation or differentiation: Use of gel stress in combination with stem cell growth factors.一种在静止、增殖或分化状态下限制乳腺癌干细胞的新方法:利用凝胶应力与干细胞生长因子相结合。
Oncol Lett. 2016 Aug;12(2):1355-1360. doi: 10.3892/ol.2016.4757. Epub 2016 Jun 22.
2
CycleFlow simultaneously quantifies cell-cycle phase lengths and quiescence .CycleFlow 可同时定量细胞周期各时相的长度和静止期。
Cell Rep Methods. 2022 Oct 6;2(10):100315. doi: 10.1016/j.crmeth.2022.100315. eCollection 2022 Oct 24.
3
Yeast cells can enter a quiescent state through G1, S, G2, or M phase of the cell cycle.酵母细胞可以通过细胞周期的G1、S、G2或M期进入静止状态。
Cancer Res. 1993 Apr 15;53(8):1867-70.
4
SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence.SET 结构域蛋白 4 通过表观遗传调控乳腺癌干细胞静止状态。
Cancer Res. 2019 Sep 15;79(18):4729-4743. doi: 10.1158/0008-5472.CAN-19-1084. Epub 2019 Jul 15.
5
A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases.一种基因工程的溶瘤腺病毒可以诱骗并在 S/G2/M 期使静止的癌症干细胞样细胞致死性地陷入陷阱。
Clin Cancer Res. 2013 Dec 1;19(23):6495-505. doi: 10.1158/1078-0432.CCR-13-0742. Epub 2013 Sep 30.
6
Distinguishing States of Arrest: Genome-Wide Descriptions of Cellular Quiescence Using ChIP-Seq and RNA-Seq Analysis.区分停滞状态:使用ChIP-Seq和RNA-Seq分析对细胞静止进行全基因组描述。
Methods Mol Biol. 2018;1686:215-239. doi: 10.1007/978-1-4939-7371-2_16.
7
Evaluation of the expression and intracellular localization of a 44-kDa calmodulin binding protein during exponential growth and quiescence (G0).评估一种44 kDa钙调蛋白结合蛋白在指数生长期和静止期(G0期)的表达及细胞内定位。
Biochem Cell Biol. 1995 Jan-Feb;73(1-2):91-104. doi: 10.1139/o95-011.
8
HER2 as a potential therapeutic target on quiescent prostate cancer cells.HER2作为静止期前列腺癌细胞的潜在治疗靶点。
Transl Oncol. 2023 May;31:101642. doi: 10.1016/j.tranon.2023.101642. Epub 2023 Feb 18.
9
Autophagy mediates serum starvation-induced quiescence in nucleus pulposus stem cells by the regulation of P27.自噬通过调节 P27 介导血清饥饿诱导的髓核干细胞静止。
Stem Cell Res Ther. 2019 Apr 15;10(1):118. doi: 10.1186/s13287-019-1219-8.
10
Quantitation of G0 and G1 phase cells in primary carcinomas. Antibody to M1 subunit of ribonucleotide reductase shows G1 phase restriction point block.
J Clin Invest. 1991 Feb;87(2):519-27. doi: 10.1172/JCI115026.

引用本文的文献

1
Bibliometric-driven research on chemoresistance in breast cancer: knowledge mapping, hotspot evolution, and emerging insights (1994-2024).基于文献计量学的乳腺癌化疗耐药性研究:知识图谱、热点演变及新见解(1994 - 2024年)
Discov Oncol. 2025 Sep 3;16(1):1676. doi: 10.1007/s12672-025-03542-8.
2
Impact of G1 phase kinetics on the acquisition of stemness in cancer cells: the critical role of cyclin D.G1期动力学对癌细胞干性获得的影响:细胞周期蛋白D的关键作用。
Mol Biol Rep. 2025 Feb 14;52(1):230. doi: 10.1007/s11033-025-10351-3.
3
Assessing the distribution of cancer stem cells in tumorspheres.

本文引用的文献

1
Targeting cancer stem cells by using the nanoparticles.利用纳米颗粒靶向癌症干细胞。
Int J Nanomedicine. 2015 Sep 10;10(Spec Iss):251-60. doi: 10.2147/IJN.S88310. eCollection 2015.
2
Subverting Subversion: A Review on the Breast Cancer Microenvironment and Therapeutic Opportunities.颠覆颠覆:乳腺癌微环境与治疗机遇综述
Breast Cancer (Auckl). 2015 Sep 15;9(Suppl 2):7-15. doi: 10.4137/BCBCR.S29423. eCollection 2015.
3
Breast Reconstruction Following Cancer Treatment.癌症治疗后的乳房重建。
评估肿瘤球中癌症干细胞的分布。
Sci Rep. 2024 May 14;14(1):11013. doi: 10.1038/s41598-024-61558-6.
4
Mitochondria in Cancer Stem Cells: From an Innocent Bystander to a Central Player in Therapy Resistance.癌症干细胞中的线粒体:从无辜旁观者到治疗抗性的核心角色
Stem Cells Cloning. 2023 Aug 23;16:19-41. doi: 10.2147/SCCAA.S417842. eCollection 2023.
5
Editorial: Drug resistance in breast cancer - mechanisms and approaches to overcome chemoresistance.社论:乳腺癌中的耐药性——克服化疗耐药的机制与方法
Front Oncol. 2023 Jan 4;12:1080684. doi: 10.3389/fonc.2022.1080684. eCollection 2022.
6
Dual or multiple drug loaded nanoparticles to target breast cancer stem cells.用于靶向乳腺癌干细胞的双药或多药负载纳米颗粒。
RSC Adv. 2020 May 19;10(32):19089-19105. doi: 10.1039/d0ra02801k. eCollection 2020 May 14.
7
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.耐药性乳腺癌干细胞样细胞:克服耐药性的机制及新型治疗策略综述
Front Oncol. 2022 Mar 21;12:856974. doi: 10.3389/fonc.2022.856974. eCollection 2022.
8
Understanding the influence of substrate when growing tumorspheres.研究在培养肿瘤球时基质的影响。
BMC Cancer. 2021 Mar 15;21(1):276. doi: 10.1186/s12885-021-07918-1.
9
Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells.癌症中细胞周期基因的改变:揭示癌症干细胞的作用。
Mol Biol Rep. 2020 Apr;47(4):3065-3076. doi: 10.1007/s11033-020-05341-6. Epub 2020 Feb 28.
10
Redox-Mediated Mechanism of Chemoresistance in Cancer Cells.癌细胞中化学抗性的氧化还原介导机制
Antioxidants (Basel). 2019 Oct 10;8(10):471. doi: 10.3390/antiox8100471.
Dtsch Arztebl Int. 2015 Aug 31;112(35-36):593-600. doi: 10.3238/arztebl.2015.0593.
4
A review of breast cancer awareness among women in India: Cancer literate or awareness deficit?印度女性乳腺癌认知情况综述:具备癌症知识还是认知不足?
Eur J Cancer. 2015 Sep;51(14):2058-66. doi: 10.1016/j.ejca.2015.07.008. Epub 2015 Jul 29.
5
Recent insights into hepatic cancer stem cells.肝癌干细胞的最新见解。
Hepatol Int. 2014 Sep;8 Suppl 2:458-63. doi: 10.1007/s12072-013-9498-0. Epub 2013 Dec 20.
6
Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.胶质母细胞瘤干细胞(GSCs)的表观遗传可塑性以及分化的非GSCs与GSCs之间的相互转化。
Genes Dis. 2015 Jun;2(2):152-163. doi: 10.1016/j.gendis.2015.02.001.
7
Stem cells, colorectal cancer and cancer stem cell markers correlations.干细胞、结直肠癌与癌症干细胞标志物的相关性。
Curr Health Sci J. 2014 Jul-Sep;40(3):153-61. doi: 10.12865/CHSJ.40.03.01. Epub 2014 Aug 4.
8
Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance.癌症干细胞:靶向癌症的根源、转移的种子以及治疗耐药性的来源。
Cancer Res. 2015 Mar 15;75(6):924-9. doi: 10.1158/0008-5472.CAN-14-3225. Epub 2015 Jan 20.
9
Curcumin as an adjuvant to breast cancer treatment.姜黄素作为乳腺癌治疗的辅助药物。
Anticancer Agents Med Chem. 2015;15(5):647-56. doi: 10.2174/1871520615666150101125918.
10
Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.二甲双胍可能通过靶向肿瘤干细胞发挥抗癌作用:肿瘤相关 miRNA 在乳腺癌和胰腺癌中的潜在生物学意义。
Ann Transl Med. 2014 Jun;2(6):59. doi: 10.3978/j.issn.2305-5839.2014.06.05.